Workflow
伟思医疗(688580) - 2020 Q3 - 季度财报
VISHEEVISHEE(SH:688580)2020-10-28 16:00

Financial Performance - Operating income for the first nine months rose by 13.17% to CNY 255,077,629.95 compared to the same period last year[7] - Net profit attributable to shareholders increased by 22.48% to CNY 85,609,917.67 compared to the same period last year[7] - Basic earnings per share increased by 14.03% to CNY 1.5549 compared to the same period last year[8] - Total revenue for Q3 2020 reached ¥98,051,173.64, an increase from ¥85,272,895.09 in Q3 2019, representing a growth of approximately 14.5%[47] - Year-to-date revenue for the first three quarters of 2020 was ¥255,077,629.95, compared to ¥225,387,606.82 in the same period of 2019, reflecting a growth of about 13.2%[47] - The company reported a net profit of ¥178,900,390.21 for the first three quarters of 2020, compared to ¥137,029,951.33 in the same period of 2019, representing an increase of about 30.5%[45] - The net profit attributable to shareholders for Q3 2020 was ¥31,974,770.39, up from ¥27,068,449.11 in Q3 2019, representing a growth of 14.1%[49] - The total profit for Q3 2020 reached ¥39,271,435.19, compared to ¥29,545,960.25 in Q3 2019, indicating a significant increase of 33.0%[51] Assets and Liabilities - Total assets increased by 263.94% to CNY 1,471,126,611.01 compared to the end of the previous year[7] - The total current assets reached ¥1,350,627,681.61, significantly up from ¥282,312,110.00 in the previous year, indicating a substantial increase in liquidity[40] - The total liabilities decreased to ¥118,039,523.12 from ¥149,353,181.67, showing a reduction of about 21%[41] - The total equity increased to ¥1,341,457,773.29 from ¥236,600,373.73, reflecting a growth of approximately 466%[45] - The total assets as of September 30, 2020, were ¥1,450,861,097.41, a significant increase from ¥374,355,023.73 at the end of 2019[44] - The total liabilities decreased to ¥109,403,324.12 from ¥137,754,650.00 in the previous year, indicating a reduction of about 20.5%[44] Cash Flow - The net cash flow from operating activities decreased by 25.96% to CNY 51,823,350.77 compared to the same period last year[7] - Cash received from operating activities increased by 39.64% year-on-year, mainly due to an increase in customer deposits and interest income[33] - Cash flow from operating activities for the first three quarters of 2020 was ¥51,823,350.77, a decrease of 26% compared to ¥69,995,238.73 in the first three quarters of 2019[55] - Cash inflow from financing activities amounted to ¥1,077,236,580.16, with a net cash flow of ¥999,697,138.98, a substantial improvement from -¥39,913,731.74 in the prior year[58] Shareholder Information - The total number of shareholders reached 5,248 by the end of the reporting period[11] - The largest shareholder, Wang Zhiyu, holds 39.45% of the shares, totaling 26,961,547 shares[11] Research and Development - Research and development expenses accounted for 9.36% of operating income, an increase of 1.19 percentage points[8] - Research and development expenses for Q3 2020 amounted to ¥8,597,071.41, compared to ¥7,106,650.55 in Q3 2019, marking an increase of approximately 21%[47] Government Subsidies - The company received government subsidies amounting to CNY 2,495,640.85 during the reporting period[9] Legal and Regulatory - The company has no significant adverse impact on its operations from the recent legal proceedings regarding patent disputes[35] - The company adopted new revenue and leasing standards starting January 1, 2020, impacting the presentation of contract liabilities[59]